{"schema_version":"secwatch.filing_event.v1","accession":"0001759655-22-000188","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.011572+00:00","generated_at":"2026-06-21T23:21:01.738307+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Privia Health adopts amended bylaws updating universal proxy and stockholder nomination procedures","bullets":["Amended bylaws require nominating stockholders to include nominee's written consent to be named in the company's proxy card.","Stockholders must represent they intend to solicit holders of at least 67% voting power for non-company nominees under Rule 14a-19.","Board reserves white proxy card for its exclusive use; other proxy cards must be a different color.","Advance notice provisions expanded to require disclosure of full notional amount of derivative or synthetic equity positions.","Stockholders cannot nominate more director candidates than positions up for election; nominees must confirm intent to serve full term."],"urls":{"canonical":"https://secwatch.observer/filing/0001759655-22-000188","json":"https://secwatch.observer/filing/0001759655-22-000188.json","markdown":"https://secwatch.observer/filing/0001759655-22-000188.md","text":"https://secwatch.observer/filing/0001759655-22-000188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000175965522000188/0001759655-22-000188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000175965522000188/prva-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T23:21:01.738307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"087cbd82f26f36c90f94c5aba9f74cb2fa070045","claim":"Privia Health Group, Inc.: Amended and restated bylaws to update director nomination procedures in light of universal proxy rules and other provisions (effective 2022-11-09).","evidence_excerpt":"On November 9, 2022, the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) approved the Company’s Second Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”), effective as of such date.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000175965522000188/0001759655-22-000188-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-11-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}